Cargando…

Juvenile Dermatomyositis

Juvenile dermatomyositis (JDM) is a systemic capillary vasculopathy. Patients present with proximal muscle weakness, raised muscle enzymes, and pathognomic skin rashes such as heliotrope rash, Gottron’s papules. Main complications are calcinosis, lipodystrophy, osteoporosis. Complement-mediated dama...

Descripción completa

Detalles Bibliográficos
Autor principal: Rhim, Jung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Rheumatology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324917/
https://www.ncbi.nlm.nih.gov/pubmed/37476697
http://dx.doi.org/10.4078/jrd.2022.29.1.14
_version_ 1785069202843893760
author Rhim, Jung Woo
author_facet Rhim, Jung Woo
author_sort Rhim, Jung Woo
collection PubMed
description Juvenile dermatomyositis (JDM) is a systemic capillary vasculopathy. Patients present with proximal muscle weakness, raised muscle enzymes, and pathognomic skin rashes such as heliotrope rash, Gottron’s papules. Main complications are calcinosis, lipodystrophy, osteoporosis. Complement-mediated damage of vessels is a major mechanism. Magnetic resonance imaging is currently widely used to diagnosis of JDM. The goals of treatment are to control inflammatory myositis and prevent disease complication. Early, aggressive treatment of JDM associated with a better prognosis. High-dose corticosteroids in combination with methotrexate is the mainstay of treatment. The course of JDM is variable.
format Online
Article
Text
id pubmed-10324917
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean College of Rheumatology
record_format MEDLINE/PubMed
spelling pubmed-103249172023-07-20 Juvenile Dermatomyositis Rhim, Jung Woo J Rheum Dis Review Article Juvenile dermatomyositis (JDM) is a systemic capillary vasculopathy. Patients present with proximal muscle weakness, raised muscle enzymes, and pathognomic skin rashes such as heliotrope rash, Gottron’s papules. Main complications are calcinosis, lipodystrophy, osteoporosis. Complement-mediated damage of vessels is a major mechanism. Magnetic resonance imaging is currently widely used to diagnosis of JDM. The goals of treatment are to control inflammatory myositis and prevent disease complication. Early, aggressive treatment of JDM associated with a better prognosis. High-dose corticosteroids in combination with methotrexate is the mainstay of treatment. The course of JDM is variable. Korean College of Rheumatology 2022-01-01 2022-01-01 /pmc/articles/PMC10324917/ /pubmed/37476697 http://dx.doi.org/10.4078/jrd.2022.29.1.14 Text en Copyright © 2022 by The Korean College of Rheumatology. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Rhim, Jung Woo
Juvenile Dermatomyositis
title Juvenile Dermatomyositis
title_full Juvenile Dermatomyositis
title_fullStr Juvenile Dermatomyositis
title_full_unstemmed Juvenile Dermatomyositis
title_short Juvenile Dermatomyositis
title_sort juvenile dermatomyositis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324917/
https://www.ncbi.nlm.nih.gov/pubmed/37476697
http://dx.doi.org/10.4078/jrd.2022.29.1.14
work_keys_str_mv AT rhimjungwoo juveniledermatomyositis